Preliminary Identification of Assessment Indicators in Transient Addiction Harm Reduction Centers: A Qualitative Study

Document Type : Scientific-research


1 PhD student in Clinical Psychology, Shahid Beheshti University. Tehran. Iran.

2 Associate Professor, Family Research Institute, Shahid Beheshti University. Tehran. Iran.

3 Assistant Professor, Counseling Department, Shahid Beheshti University. Tehran. Iran.

4 Associate Professor, Department of Clinical Psychology, Shahid Beheshti University. Tehran. Iran

5 Assistant Professor of Psychiatry, National Center for Addiction Studies, Tehran University of Medical Sciences. Tehran. Iran.



Aim: This study aimed to identify the indicators for evaluating the quality of services of transit centers to reduce damage and to develop a tool to measure these indicators to provide an optimal model for improving services in these centers. Methods: This research was carried out using a qualitative and content analysis method. The statistical population included people associated with addiction harm reduction centers (including those referred to harm reduction centers and staff working in transit centers). Data were collected through purposive and available sampling and in-depth semi-structured interviews with 20 people. They were analyzed using a six-step content analysis method based on the six-step approach of Brown and Clark. Results: Analysis of participants' experiences led to identification of 2-main themes (services and organizational structure) and 15 sub-themes (syringe and needle program, HIV counseling and testing program, welfare services, low-threshold methadone maintenance treatment program, referral to levels Others became founders, staff, support organizations, physical environment, monitoring and supervision, training program, mobile relief team, statistics and information, performance, social and responsible support). Conclusion: The indicators obtained in the present study, which are based on the experience of employees, therapists and people who refer to harm reduction centers, can be used as an acceptable indicator in evaluating and monitoring the quality of service provided by these centers.


مشکاتی، مرجان؛ عطایی، بهروز؛ نخودیان، زری؛ یاران، مجید؛ بابک، آناهیتا؛ عسگریان‏زاده، محمدرضا؛ فرشاد، مرضیه؛ و ادیبی، پیمان. (1389). غربالگری هپاتیت در مراکز گذری استان اصفهان: توصیف یک تجربه. مجلۀ دانشکدۀ پزشکی اصفهان، 28، 1559-1553.
Abou-Saleh, M.T. (2006). Substance use disorder: Recent advances in treatment and models of care. Journal Psychology Research, 61(9), 305-310.
Bartholomew, T.S., Patel, H., McCollister, K., Feaster, D. j., Tookes, H. E.  (2021). Implementation and first-year operating costs of an academic medical center-based syringe services program. Harm Reduction Journal. 18(116).
Bobrova, N., Rughnikov, U., Neifeld, E., Rhodes, T., Alcorn, R., Kirichenko, S., & Power, R. (2008). Challenges in providing drug user treatment services in Russia: Providers’ views. Substance Use and Misuse, 43(12–13), 1770–1784.
Centers for Disease Control and Prevention [CDC] . (2021). Wide-ranging online data for epidemiologic research (WONDER). 2020.
Chen, W.J., Chen, CY., Wu, SC. Wu, K.C.C, Jou, S,. Tung, Y.C. (2021).  The impact of Taiwan’s implementation of a nationwide harm reduction program in 2006 on the use of various illicit drugs: trend analysis of first-time offenders from 2001 to 2017. Harm Reduction Journal. 18, 117.
Childs, E., Biello, K., Valente, P. K., Salhaney, P., Biancarelli, D. L., Olson, J., Earlywine, J. J,. Marshall, B. D. L,. Bazzi, A. R. (2021). Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: a qualitative study exploring challenges and mitigating strategies.
International Journal of Drug Policy
. 90-103080.
Des Jarlais, D. C., McKnight, C., Goldblatt, C., Purchase, D. (2009). Doing harm reduction better: syringe exchange in the United States. Addiction. 104(9):1441–6.
Dechman, M. K. (2015). Peer helpers’ struggles to care for “others” who inject drugs. International Journal of Drug Policy. 26(5):492–500.
Dastjerdi, G. H., Ebrahimi, V., Kholasezade, G., & Ehsani. F. (2010). The effects of methadone on reducing high-risk behaviors. Journal of Shahid Sadoughi University of Medical Sciences, 18(3), 215-219.
Fernandes, R. M., Cary, M., Duarte, G., Jesus, G., Alarcão, J., Torre, C., Costa, S., Costa, J., Carneiro, A. V. (2017) Effectiveness of needle and syringe programmes in people who inject drugs - An overview of systematic reviews. BMC Public Health , 17 , (1) , 309.
Friedman, S. R., de Jong, W., Rossi, D., Touzé, G., Rockwell, R., Des Jarlais, D. C., & Elovich, R. (2007). Harm reduction theory: Users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups. International Journal of Drug Policy18(2), 107-117.
Genberg, B.L., Shangani, S., Sabatino, K., Rachlis, B., Wachira, J., Braitstein, P.,  Operario, D. (2016).Improving Engagement in the HIV Care Cascade: A Systematic Review of Interventions Involving People Living with HIV/AIDS as Peers. AIDS and Behavior.20, 2452–2463 (2016).
Gibson, D. R., Brand, R., Anderson, K., Kahn, J. G., Perales, D., Guydish, J. (2002). Two- to six-fold decreased odds of risk behavior associated with use of syringe exchange. Journal of Acquired Immune Deficiency Syndromes.
Ghiasi, M., Farahbakhsh, M., Hekmatpour, A. (2013). Assessment of harm reduction programs in behavioral health clinics (triangle) for covered veterans. Iranian Journal of War and Public Health.  5 (3) : 1 -6.
Gratz, K. L., & Tull, M. T. (2010). The relationship between emotion dysregulation and deliberate self-harm among inpatients with substance use disorders. Cognitive Therapy and Research, 34(6), 544-553.
Roshanfekr P, Farnia M, Dejman M. The Effectiveness of Harm Reduction Programs in Seven Prisons of Iran. Iran Journal Public Health. 2013 Dec;42(12):1430-7.
He, J., Wang, Y., Du, Z. Liao, J., He, N., Hao, Y. (2020).Peer education for HIV prevention among high-risk groups: a systematic review and meta-analysis. BMC Infectious Diseases, 20, 338.
Hope, V.,  Marongiu, A.,  Parry, J. V.,  Ncube, F. (2010). The extent of injection site infection in injecting drug users: findings from a national surveillance study. Epidemiology & Infection. 138(10):1510–8.
Holeksa, J. (2022). Dealing with low access to harm reduction: a qualitative study of the strategies and risk environments of people who use drugs in a small Swedish city. Harm Reduction Journal. 19, 23.
Hobden, K. L., Cunningham, J. A. (2006). Barriers to the dissemination of four harm reduction strategies: a survey of addiction treatment providers in Ontario. Harm Reduction Journal.  3 : 35
Iryawan, A.R., Stoicescu, C., Sjahrial, F. (2022). The impact of peer support on testing, linkage to and engagement in HIV care for people who inject drugs in Indonesia: qualitative perspectives from a community-led study. Harm Reduction Journal. 19, 16.
Logan, D. E., & Marlatt, G. A. (2010). Harm reduction therapy: A practice‐friendly review of research. Journal of Clinical Psychology, 66(2), 201-214.
Levine, H.,  Bartholomew, T. S.,  Rea-Wilson, V.,  Onugha, J.,  Arriola D. J., Cardenas, G., Forrest, D. W,.,  Kral,  A. H., MetschL. R.,  Spencer, E.,  Tookes, H. (2019). Syringe disposal among people who inject drugs before and after the implementation of a syringe services program. Drug and Alcohol Dependence. 202:13–7.
Marlatt, G. A., Larimer, M. E., & Witkiewitz, K. (2012). Harm reduction: Pragmatic strategies for managing high-risk behaviors. Guilford Press.
Mahdavi, P. (2009). Passionate uprisings: Iran's sexual revolution. Stanford University Press.
Musyoki, H., Bhattacharjee, P., Sabin, K., Ngoksin, E., Wheeler, T., Dallabetta, G. (2021). A decade and beyond: learnings from HIV programming with underserved and marginalized key populations in Kenya. Journal of the International AIDS Society. 24: 25729.
Muñoz, F., Burgos, J. L., Cuevas-Mota, J., Teshale, E., Garfein, R. S. (2015). Individual and socio-environmental factors associated with unsafe injection practices among young adult injection drug users in San Diego. AIDS and behavior. 19(1):199–210.
Tavakol, M., Naserirad, M., Avanessian, E., Anis, S., & Abrahamian, H. (2016). Differential Quality Assessment of Harm Reduction Service in Drop-in Centers and Shelters: from expectations to perceptions. Journal of Health Literacy, 1(2), 118-128.  
Kerr, T., Small, W., Buchner, C., Zhang, R., Li, K., Montaner, J., Wood, E. (2010). Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Amirican Journal of Public Health. 100(8):1449–53.
Ravaghi, H., Zandian, H., Afsar Kazerooni, P., Sabet, M., Mostafavi, H., Alipouri Sakha. M. (2017). Challenges and Successes of Harm Reduction Services in Drop-in Centers: Perspectives of Service Providers International Journal Of High Risk Behaviors And Addiction.;6(2): 29391.
Ritter, A., & Cameron, J. (2006). A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug and Alcohol Review, 25(6), 611-624.
Roshanfekr, P., Farnia, M., & Dejman, M. (2013). The effectiveness of harm reduction programs in seven prisons of Iran. Iranian Journal of Public Health, 42(12), 1430-1437.
Ruiz, M. S., O'Rourke, A., Allen, S., Holtgrave, D. R., Metzger, D., Benitez, J., Brady, K. A., Chaulk, C. P., Wen, L. S. (2019). Using interrupted time series analysis to measure the impact of legalized syringe exchange on HIV diagnoses in Baltimore and Philadelphia. Journal of Acquired Immune Deficiency Syndromes (1999). 82(2):148.
Suen, L.W., Makam, A.N., Snyder, H.R.  Repplinger, D., Kushel M. B.,­ Martin, Ma.,  Nguyen, O. K.  (2021). National Prevalence of Alcohol and Other Substance Use Disorders Among Emergency Department Visits and Hospitalizations: NHAMCS 2014–2018. JAIDS Journal of Acquired Immune Deficiency Syndromes. 13, 1-9.
Stone, J., Fraser, H., Walker, J. G., Mafirakureva, N., Mundia, B., Cleland, C., Kigen, B., Musyoki, H., Waruiru, W., Ragi, A., Bhattacharjee, P., Chhun, N., Lizcano, J., Akiyama, M., Cherutich, P., Wisse, E., Kurth, A., Luhmann, N., & Vickerman, P. T. (Accepted/In press). Modelling the Impact of HIV and HCV Prevention and Treatment Interventions Among People Who Inject Drugs in Kenya. AIDS.
Strathdee, S. A., Hallett, T.B., Bobrova, N., Rhodes, T., Booth, R., Abdool, R., Hankins, C. A. (2010). HIV and risk environment for injecting drug users: the past, present, and future. The Lancet. 376(9737):268–84.
Stoicescu, C. Booklet 3: voluntary community-based alternatives: discussion paper of the UNAIDS–UNODC Asia–Pacific Expert Advisory Group on Compulsory Facilities for People Who Use Drugs. Bangkok: UNODC Regional Office for Southeast Asia and the Pacific, UNAIDS Regional Support Team for Asia and the Pacific; 2022.
Tavakol, M., Naserirad, M., Avanessian, E., Anis, S., & Abrahamian, H. (2016). Differential Quality Assessment of Harm Reduction Service in Drop-in Centers and Shelters: from expectations to perceptions. Journal of Health Literacy, 1(2), 118-128.
World Health Organization. (2015). Consolidated guidelines on HIV testing services. Geneva: WHO.
UNODC. (2017).Implementing comprehensive HIV and HCV programmes with people who inject drugs: practical guidance for collaborative interventions. Vienna: United Nations Office on Drugs and Crime.